U.S. License Holder:
Bio-Thera Solutions / Sandoz
Date of License:
aBLA accepted by FDA January-2021
Last Update:
Nov-30-2023
FDA-Approved Indications
BAT1706 (bevacizumab) is not FDA-approved. An aBLA has been accepted by the FDA.